Polycystic ovary syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
Aditya Ganti (talk | contribs)
Aditya Ganti (talk | contribs)
Line 8: Line 8:


==Medical Therapy==
==Medical Therapy==
The first step in the management of PCOS is weight loss if the patient is obese, and treatment of type 2 diabetes, if present, with metformin. In significantly overweight patients, weight loss alone usually effects a cure and should always be vigorously attempted. Diet and exercise are recommended in all women with PCOS. The next step is initiation of treatment to break the self-perpetuating anovulatory cycling, either by stimulating ovulation or suppressing androgenic and ovarian activity. The selection of treatment depends on whether pregnancy is desired. All antiandrogen treatments will take at least 3 months to affect hirsutism.
The first step in the management of PCOS is weight loss if the patient is [[obese]], and treatment of [[type 2 diabetes]], if present, with [[metformin]]. In significantly overweight patients, weight loss alone usually effects a cure and should always be vigorously attempted. Diet and exercise are recommended in all women with PCOS. The next step is initiation of treatment to break the self-perpetuating [[annovulation|anovulatory cycling]], either by stimulating ovulation or suppressing androgenic and ovarian activity. The selection of treatment depends on whether pregnancy is desired. All anti-androgen treatments will take at least 3 months to affect hirsutism.
The goals of treatment are:
The goals of treatment are:
*Exclude androgen-secreting tumors, endometrial tumors, and endometrial hyperplasia
*Exclude androgen-secreting tumors, endometrial tumors, and endometrial hyperplasia
*Reduce ovarian androgen secretion and/or antagonist activity at target tissues
*Reduce ovarian androgen secretion and/or antagonist activity at target tissues
*Interrupt the self-sustaining abnormal hormonal cycle
*Interrupt the self-sustaining abnormal hormonal cycle
*Normalize the endometrium
*Normalize the [[endometrium]]
*Restore fertility by correcting anovulation, if desired
*Restore fertility by correcting [[anovulation]], if desired
*Reduce insulin resistance
*Reduce [[insulin resistance]]
==If fertility is not desired==
*Preferred regimen (1): Combined [[|OCP|oral contraceptive pills]] one tablet of formulations containing 30 to 35 μg [[estrogen]] orally daily for 21 days, then nothing for 7 days
*Preferred regimen (2): Progesterone-only contraceptive pills (eg, [[norethindrone]], [[norgestrel]] ) are the treatment of choice if combined [[OCP|oral contraceptive pills]] are contraindicated
*Alternative regimen(1): [[Medroxyprogesterone]] may be used, although it is not approved by the U.S. Food and Drug Administration (FDA) for this indication
*Alternative regimen(2): [[Glucocorticoids]] (eg, [[hydrocortisone]], [[cortisone]], [[dexamethasone]] ) may be used to suppress adrenal androgen production, although they are not approved by the FDA for this indication
*Alternative regimen(3): [[Spironolactone]] and [[flutamide]] are androgen receptor antagonists that may be added to the oral contraceptive pill, but they are not approved by the FDA for this indication; [[flutamide]] is not usually recommended because of its unproven efficacy and associated risk of hepatic impairment
==If fertility is desired==
*Preferred regimen (1): [[Clomiphene]], alone or in combination with [[glucocorticoids]], is the first-choice treatment
*Preferred regimen (2): [[FSH|Follicle-stimulating hormone]] may be administered in conjunction with timed [[HCG|human chorionic gonadotropin]] for [[ovulation]] induction
*Preferred regimen (3): [[Metformin]]


==References==
==References==

Revision as of 14:07, 2 August 2017

Polycystic ovary syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic ovary syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycystic ovary syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic ovary syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic ovary syndrome medical therapy

CDC on Polycystic ovary syndrome medical therapy

Polycystic ovary syndrome medical therapy in the news

Blogs on Polycystic ovary syndrome medical therapy

Directions to Hospitals Treating Polycystic ovary syndrome

Risk calculators and risk factors for Polycystic ovary syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Medical Therapy

The first step in the management of PCOS is weight loss if the patient is obese, and treatment of type 2 diabetes, if present, with metformin. In significantly overweight patients, weight loss alone usually effects a cure and should always be vigorously attempted. Diet and exercise are recommended in all women with PCOS. The next step is initiation of treatment to break the self-perpetuating anovulatory cycling, either by stimulating ovulation or suppressing androgenic and ovarian activity. The selection of treatment depends on whether pregnancy is desired. All anti-androgen treatments will take at least 3 months to affect hirsutism. The goals of treatment are:

  • Exclude androgen-secreting tumors, endometrial tumors, and endometrial hyperplasia
  • Reduce ovarian androgen secretion and/or antagonist activity at target tissues
  • Interrupt the self-sustaining abnormal hormonal cycle
  • Normalize the endometrium
  • Restore fertility by correcting anovulation, if desired
  • Reduce insulin resistance

If fertility is not desired

  • Preferred regimen (1): Combined [[|OCP|oral contraceptive pills]] one tablet of formulations containing 30 to 35 μg estrogen orally daily for 21 days, then nothing for 7 days
  • Preferred regimen (2): Progesterone-only contraceptive pills (eg, norethindrone, norgestrel ) are the treatment of choice if combined oral contraceptive pills are contraindicated
  • Alternative regimen(1): Medroxyprogesterone may be used, although it is not approved by the U.S. Food and Drug Administration (FDA) for this indication
  • Alternative regimen(2): Glucocorticoids (eg, hydrocortisone, cortisone, dexamethasone ) may be used to suppress adrenal androgen production, although they are not approved by the FDA for this indication
  • Alternative regimen(3): Spironolactone and flutamide are androgen receptor antagonists that may be added to the oral contraceptive pill, but they are not approved by the FDA for this indication; flutamide is not usually recommended because of its unproven efficacy and associated risk of hepatic impairment

If fertility is desired

References


Template:WikiDoc Sources